Reports – Pfizer
Report 40: “Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA.”
So much has been written about the pivotal Pfizer Trial for COVID-19 (C4591001), that it is sometimes hard to remember that the ‘primary evaluable efficacy’ analysis [Follman DA, 2007) Follmann, D.A. (2007). Primary Efficacy Endpoint. Wiley Encyclopedia of Clinical Trials. https://onlinelibrary.wiley.com/doi/10.1002/9780471462422.eoct341], was granted on the results of 170 subjects out …
Report 39: “2021 CDC and FDA Misinformation – Retroactive Editing, Erroneous Spontaneous Abortion Rate Calculation, Obfuscation in the New England Journal of Medicine”
The following article is a follow-up to Dr. Chandler’s report, “Data Do Not Support Safety of mRNA COVID Vaccination for Pregnant Women,” [https://dailyclout.io/data-do-not-support-safety-of-mrna-covid-vaccination-for-pregnant-women/] which reviewed “Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons,” New England Journal of Medicine, April 21, 2021, and June 17, 2021. To best understand …
Report 38: “Data Do Not Support Safety of mRNA COVID Vaccination for Pregnant Women”
Commentary on Preliminary Findings of “mRNA Covid Vaccine Safety in Pregnant Persons” as Reported by the Centers for Disease Control and Prevention and the Food and Drug Administration, June 17, 2021, New England Journal of Medicine. Currently, the Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices …
Report 37: “Despite Incomplete Safety Trials, the Food and Drug Administration (FDA) Grants Full Approval to Pfizer-BioNTech’s COMIRNATY® for Adolescents 12-15 Years of Age”
Without a completed safety study or expert committee review, the FDA issued a supplemental Biologics License Application (“sBLA”) approval letter granting full FDA approval to Pfizer-BioNTech’s COMIRNATY® COVID-19 mRNA vaccine for use in children ages 12-15. This was done even though safety study completion, on which approval should be based, …
Report 20: “What Did Pfizer Know, and When Did They Know It? Neurological Harms Concealed.”
This report assists in answering, “What did Pfizer know, and when did they know it?” concerning its COVID-19 vaccine. The report focuses on neurological complaints post-injection with the Pfizer COVID-19 vaccine, as well as on several other, non-neurological reported symptoms. The information presented comes from the Centers for Disease Control …
Report 9: ”Even Big Pharma CEOs recognized that not everyone could be vaccinated – so why Vaccine Mandates?”
Recently, Project Veritas revealed that the CEO of AstraZeneca, Pascal Soriot, told his company in a Zoom call in Dec 2020 that not everyone could be vaccinated; Soriot identified the immune-compromised and people with multiple sclerosis as examples if those who should not be vaccinated with mRNA vaccines. He raised …
Report 8: “Why Was the Pfizer COVID-19 Vaccine Recommended for Use in and Administered to Children When It Was Not Tested in That Age Group?”
Thanks to a court-ordered release of confidential Pfizer documents we have learned that 21 groups of individuals were excluded from phase 1, 2 and 3 of their human trials. Children under the age of 18 were one of these excluded groups. https://www.phmpt.org/wp-content/uploads/2022/04/125742_S1_M5_5351_c4591001-fa-interim-sam-ple-crf.pdf (Annotated Study Book for Study Design: C4591001 Study …
Report 6: “Safe and Effective? We Beg to Differ. Red Flags in the Pfizer Internal Documents.”
Pfizer released the documents on their early efficacy and safety trials of their vaccine. (Pfizer 2.7.3 SUMMARY OF CLINICAL EFFICACY). https://phmpt.org/wp-content/uploads/2021/12/STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf. The results of these documents are used to justify the claim the vaccines are safe and effective. Examine the document! It is evident beyond any doubt. Pfizer lied and …
Report 4: “Review of ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine’
Team Five: Review of Polack with comments and questions. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Fernando P. Polack, M.D., Stephen J. Thomas, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Gonzalo Perez Marc, M.D., Edson D. Moreira, M.D., …
Report 3: “Phase 1 /2 Study of COVID-19 RNA Vaccine BNT162b1 in Adults: Key Processes Missing.”
Phase 1 / 2 study of Covid-19 RNA vaccine BNT162b1 in Adults Mulligan, Lyke et al. Nature Published online 8/12/2020. Cite this article as: Mulligan, M. J. et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature https://doi. org/10.1038/s41586-020-2639-4 (2020). P1 p2: The authors’ put forth the …